Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Sander, Clare R
3779  Ergebnisse:
Personensuche X
?
1

A positive BAL galactomannan in non-haemato-oncology patien..:

Martinelli, Anthony W. ; Patil, Parth ; Wong, Vanessa K...
Journal of Medical Microbiology.  68 (2019)  12 - p. 1766-1770 , 2019
Link: https://doi.org/10.1099/..
 
?
2

British Lung Foundation/United Kingdom Primary Immunodefici..:

Hurst, John R. ; Verma, Nisha ; Lowe, David...
The Journal of Allergy and Clinical Immunology: In Practice.  5 (2017)  4 - p. 938-945 , 2017
Link: https://doi.org/10.1016/..
 
?
3

Serum indoleamine 2,3-dioxygenase activity is associated wi..:

Tanner, Rachel ; Kakalacheva, Kristina ; Miller, Ellen...
BMC Infectious Diseases.  14 (2014)  1 - p. , 2014
Link: https://doi.org/10.1186/..
 
?
4

Effect of vaccine dose on the safety and immunogenicity of ..:

Pathan, Ansar A. ; Minassian, Angela M. ; Sander, Clare R....
Vaccine.  30 (2012)  38 - p. 5616-5624 , 2012
Link: https://doi.org/10.1016/..
 
?
5

Correction: Immunisation with BCG and recombinant MVA85A in..:

Beveridge, Natalie E. R. ; Price, David A. ; Casazza, Joseph P....
European Journal of Immunology.  41 (2011)  5 - p. 1501-1501 , 2011
Link: https://doi.org/10.1002/..
 
?
6

Correction: Boosting BCG with Recombinant Modified Vaccinia..:

Pathan, Ansar A. ; Sander, Clare R. ; Fletcher, Helen A....
PLoS ONE.  6 (2011)  2 - p. , 2011
Link: https://doi.org/10.1371/..
 
?
7

Correction: Safety and Immunogenicity of Boosting BCG Vacci..:

Whelan, Kathryn T. ; Pathan, Ansar A. ; Sander, Clare R....
PLoS ONE.  6 (2011)  2 - p. , 2011
Link: https://doi.org/10.1371/..
 
?
8

A Phase I study evaluating the safety and immunogenicity of..:

Minassian, Angela M ; Rowland, Rosalind ; Beveridge, Natalie E R...
BMJ Open.  1 (2011)  2 - p. e000223 , 2011
Link: https://doi.org/10.1136/..
 
?
9

Th1/Th17 Cell Induction and Corresponding Reduction in ATP ..:

Griffiths, Kristin L. ; Pathan, Ansar A. ; Minassian, Angela M....
PLoS ONE.  6 (2011)  8 - p. e23463 , 2011
Link: https://doi.org/10.1371/..
 
?
10

Safety and Immunogenicity of Boosting BCG Vaccinated Subjec..:

Whelan, Kathryn T. ; Pathan, Ansar A. ; Sander, Clare R....
PLoS ONE.  4 (2009)  6 - p. e5934 , 2009
Link: https://doi.org/10.1371/..
 
?
11

A comparison of IFNγ detection methods used in tuberculosis..:

Beveridge, Natalie E.R. ; Fletcher, Helen A. ; Hughes, Jane...
Tuberculosis.  88 (2008)  6 - p. 631-640 , 2008
Link: https://doi.org/10.1016/..
 
?
12

Boosting BCG vaccination with MVA85A down-regulates the imm..:

Fletcher, Helen A. ; Pathan, Ansar A. ; Berthoud, Tamara K....
Vaccine.  26 (2008)  41 - p. 5269-5275 , 2008
Link: https://doi.org/10.1016/..
 
?
13

Boosting BCG with Recombinant Modified Vaccinia Ankara Expr..:

Pathan, Ansar A. ; Sander, Clare R. ; Fletcher, Helen A....
PLoS ONE.  2 (2007)  10 - p. e1052 , 2007
Link: https://doi.org/10.1371/..
 
?
14

Boosting BCG with MVA85A: the first candidate subunit vacci..:

McShane, Helen ; Pathan, Ansar A. ; Sander, Clare R....
Tuberculosis.  85 (2005)  1-2 - p. 47-52 , 2005
Link: https://doi.org/10.1016/..
 
?
15

Recombinant modified vaccinia virus Ankara expressing antig..:

McShane, Helen ; Pathan, Ansar A ; Sander, Clare R...
Nature Medicine.  10 (2004)  11 - p. 1240-1244 , 2004
Link: https://doi.org/10.1038/..
 
1-15